← Back to overview

PODD Insulet Corporation

Health Care Equipment · $163.26 +3.08%
EN PL
Price Alert:

Compare

Shows % change over the period so different-priced stocks can be compared fairly.

Technical Indicators

RSI (14)
37.7
Relative Strength Index (RSI): measures how fast and how much the price has moved recently, on a 0-100 scale. Above 70 is often called "overbought" (may be due for a pause or pullback); below 30 is "oversold" (may be due for a bounce). It is not a guarantee either way.
SMA 20 / 50 / 200
253.72 / 241.12 / 124.49
Moving Averages (SMA): the average closing price over the last N days, smoothing out day-to-day noise. When price trades above its moving averages, and shorter averages are above longer ones, it is generally read as a healthier trend.
MACD / Signal
-22.60 / -5.86
MACD: compares two moving averages (12-day and 26-day) to gauge momentum. When the MACD line crosses above its signal line, momentum is turning up; crossing below suggests momentum turning down.

Fundamentals

P/E
38.1
Price-to-Earnings ratio: how many dollars investors pay for $1 of the company's annual profit. Higher usually means the market expects faster growth (or the stock is expensive); lower can mean it's cheap — or that growth is expected to slow.
Market Cap
11.31B
Market Capitalization: the total value of all the company's shares — share price × number of shares. A rough measure of company size.
Div Yield
Dividend Yield: the annual cash dividend paid to shareholders, as a percentage of the current share price.
52-Week Range
138.79 – 354.88
52-Week Range: the lowest and highest price the stock has traded at over the last year. Where the price sits in this range hints at recent strength or weakness.

Trend Analysis

Insulet Corporation is trading at $163.26, +3.08% versus the previous close. The price is near its 52-week low — the bottom of its recent trading range.
RSI is in a neutral range — no strong overbought/oversold signal.
The 50-day average is above the 200-day average ("golden cross" territory) — a commonly watched bullish signal.
MACD is below its signal line — momentum currently leans negative.
Combine this reading with the fundamentals below before forming a view — no single indicator is a guarantee of what happens next.

Latest News

Insulet's Q2 2026 Earnings: What to Expect
Barchart · 2026-07-22 12:43
Goldman Flags 3 AI-Resistant Investment Themes to Watch
Barrons.com · 2026-07-20 16:43
1 Healthcare Stock to Target This Week and 2 We Brush Off
StockStory · 2026-07-20 12:15
3 Quality Compounders on Our Buy List
StockStory · 2026-07-15 10:53
Insulet, Calm Form Partnership Targeting Diabetes Community With Wellness Products
MT Newswires · 2026-07-14 08:00
Insulet Partners with Calm to Bring Mindfulness and Well-Being Tools to the Diabetes Community, Featuring a New Sleep Story Narrated by Lila Moss
Business Wire · 2026-07-14 07:00
Global Blood Glucose Monitoring System Market Size to Reach USD 39.4 Billion by 2035 | Growing at 8.9% CAGR | Industry Trends, Market Share & Forecast – Custom Market Insights
GlobeNewswire · 2026-07-14 04:30
Insulet Corporation (PODD) Fell Along with Broad Medtech Sector
Insider Monkey · 2026-07-13 13:49
Educational information only. Nothing here is investment advice — always do your own research and consider talking to a licensed financial advisor before buying or selling.
Data: Yahoo Finance, refreshed periodically and cached locally.